Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Rubius Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 25K | May 12, 2022 | Direct | ||
Galecto, Inc. | Director | Stock Option (right to buy) | 18K | Jun 20, 2024 | Direct | ||
Kaleido Biosciences, Inc. | Director | Stock Option (Right to Buy) | 15K | Jun 30, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GLTO | Galecto, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
GLTO | Galecto, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
GLTO | Galecto, Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
RUBY | Rubius Therapeutics, Inc. | May 12, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
KLDO | Kaleido Biosciences, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |
GLTO | Galecto, Inc. | May 26, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |
RUBY | Rubius Therapeutics, Inc. | May 12, 2021 | 1 | $0 | 4 | May 13, 2021 | Director |